merck should react depending on the licensing costs.Based on the information we analysed, we have determined that the Net Present Value (NPV) of the Davanrik compound is $13.98M. The value of the contract for LAB Pharamaceuticals is $16.86M.This is a high risk high reward scenario, so Merck & co. should carefully hedge their bets in refreshing their phamaceutical porlfolio